Newsroom
Sorted by: Latest
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 2/10/2026 Issue ¦ Barclaycard Funding PLC 15 - 1 GBP 1,764,706,000 FRN due November 2023 ISIN Number ¦ GB009A2Y8IO2 ISIN Reference ¦ 009A2Y8IO Issue Nomin GBP ¦ 1764706000 Period ¦ 1/15/2026 to 2/17/2026 Payment Date 2/17/2026 Number of Days ¦ 33 Rate ¦ 5.0765 Denomination GBP ¦ 1000 ¦ 1764706000 ¦ Amount Payable per Denomination ¦ 4.59 ¦ 8099492.88 ¦ Bank of New York ...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 2/10/2026 Issue ¦ Gracechurch Card Programme Funding PLC - Series 13 - 3 Class A GBP 1,400,000,000 FRN due Jun 2024 ISIN Number ¦ XS0992306141 ISIN Reference ¦ 99230614 Issue Nomin GBP ¦ 1400000000 Period ¦ 1/15/2026 to 2/17/2026 Payment Date 2/17/2026 Number of Days ¦ 33 Rate ¦ 4.2315 Denomination GBP ¦ 1000 ¦ 1400000000 ¦ Amount Payable per Denomination ¦ 3.83 ¦ 5356035.62 ¦...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 2/10/2026 Issue ¦ Barclaycard Funding PLC - Series 14 - 2 GBP 1,886,793,000 FRN due Jun 2024 ISIN Number ¦ GB009A2G4OW4 ISIN Reference ¦ 009A2G4OW Issue Nomin GBP ¦ 1886793000 Period ¦ 1/15/2026 to 2/17/2026 Payment Date 2/17/2026 Number of Days ¦ 33 Rate ¦ 4.9155 Denomination GBP ¦ 1000 ¦ 1886793000 ¦ Amount Payable per Denomination ¦ 4.44 ¦ 8385192.4 ¦ Bank of New York...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 2/10/2026 Issue ¦ Barclaycard Funding PLC - Series 13 - 3 GBP 1,647,059,000 FRN due 15 June 2024 ISIN Number ¦ GB009A22W683 ISIN Reference ¦ 009A22W68 Issue Nomin GBP ¦ 1647059000 Period ¦ 1/15/2026 to 2/17/2026 Payment Date 2/17/2026 Number of Days ¦ 33 Rate ¦ 4.9065 Denomination GBP ¦ 1000 ¦ 1647059000 ¦ Amount Payable per Denomination ¦ 4.44 ¦ 7306376.29 ¦ Bank of New...
-
NYSE: RAL Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Ralliant Corporation (NYSE: RAL) Investors to Contact the Firm
RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Ralliant Corporation (NYSE: RAL). On February 4, 2026, Ralliant Corporation reported its fourth quarter and full year 2025 financial results and revealed a $1.4 billion non-cash goodwill impairment charge recorded in the Test & Measurement segment, which the company stated was mainly driven by revised exp...
-
Samenvatting: Xsolla brengt expertise in mobielgerichte monetisatie naar Gamesforum Barcelona 2026, waar de leiders van de Europese mobiele gamingindustrie samenkomen om de grootste groeiproblemen van de sector op te lossen
LOS ANGELES--(BUSINESS WIRE)--Xsolla, een wereldwijd bedrijf voor videogamehandel dat ontwikkelaars helpt bij het lanceren, ontwikkelen en monetiseren van hun games, heeft vandaag zijn deelname aangekondigd aan Gamesforum Barcelona 2026, dat plaatsvindt op 10 en 11 februari in het InterContinental Hotel in Barcelona. Dit evenement brengt de scherpste geesten van de Europese mobiele gamingindustrie samen voor praktische, datagedreven sessies die zich richten op wat daadwerkelijk werkt in het hui...
-
Xsolla offre son expertise en monétisation mobile-first au Gamesforum Barcelona 2026 : là où les leaders européens du jeu mobile se réunissent pour résoudre les défis de croissance les plus complexes du secteur
LOS ANGELES--(BUSINESS WIRE)--Xsolla, entreprise internationale de distribution de jeux vidéo qui accompagne les développeurs dans le lancement, le développement et la monétisation de leurs jeux, annonce aujourd'hui sa participation au Gamesforum Barcelona 2026, qui se tiendra les 10 et 11 février à l'hôtel InterContinental de Barcelone. Cet événement réunit les plus grands experts européens du jeu mobile qui participeront à des sessions pratiques orientées données, axées sur les stratégies per...
-
Riassunto: Xsolla porta il suo know-how nel settore della monetizzazione ottimizzata sui dispositivi mobili al Gamesforum Barcelona 2026, dove i leader europei del mobile gaming si riuniscono per risolvere i problemi di crescita più difficili del settore
LOS ANGELES--(BUSINESS WIRE)--Xsolla, un’azienda internazionale nel settore dei videogiochi che aiuta gli sviluppatori a lanciare, far crescere e monetizzare i loro titoli, oggi ha annunciato la sua partecipazione al Gamesforum Barcelona 2026, che si terrà il 10 e 11 febbraio presso l’Hotel InterContinental di Barcellona. Questo evento riunisce le menti più brillanti del mobile gaming in Europa per sessioni pratiche e basate sui dati, focalizzate su ciò che funziona realmente nell’attuale panor...
-
Resumen: Xsolla lleva su experiencia en monetización enfocada en móviles al Gamesforum Barcelona 2026, donde los líderes de la industria de videojuegos móviles de Europa se reúnen para resolver los desafíos de crecimiento más complejos del sector
LOS ÁNGELES--(BUSINESS WIRE)--Xsolla —una empresa global de comercio de videojuegos que ayuda a crecer a los desarrolladores para que lancen y moneticen sus juegos— anunció hoy su participación en el Gamesforum Barcelona 2026, que se celebrará del 10 al 11 de febrero en el hotel InterContinental de Barcelona. Con sesiones prácticas basadas en datos y orientadas a lo que realmente funciona en la práctica competitiva actual de la tecnología móvil, este evento reúne a las mentes más brillantes de...
-
Vynca Appoints Veteran Palliative Care Leader Jill Schwartz-Chevlin, MD, MBA, FACP, as Chief Medical Officer
SAN FRANCISCO--(BUSINESS WIRE)--Vynca, a health technology and services company supporting individuals with serious illness and complex needs, today announced the appointment of Jill Schwartz-Chevlin, MD, MBA, FACP, as Chief Medical Officer. In this role, Dr. Schwartz-Chevlin will lead Vynca’s clinical strategy, guiding the integration of tech-enabled palliative care, predictive analytics, and scalable care models to improve patient outcomes while reducing avoidable care utilization for health...
